CDKN2A and diffuse large B-cell lymphoma: The most highly mutated genes, such as MYC, TERT, FASLG, RIPK1, TNFSF10, TARDBP, and CDKN2A, have been well characterized in liver cancer (15, 48), diffuse large B-cell lymphoma (49), neuroblastoma (50), and kidney renal clear cell carcinoma (51, 52).